Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000228590 | SCV000285551 | likely benign | Werner syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003316247 | SCV004016250 | likely benign | Wiskott-Aldrich syndrome | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003401171 | SCV004103543 | uncertain significance | WRN-related disorder | 2024-02-13 | no assertion criteria provided | clinical testing | The WRN c.3101A>T variant is predicted to result in the amino acid substitution p.Tyr1034Phe. This variant was reported in an individual with dyskeratosis/aplastic anemia (Patient #48, Arias-Salgado et al. 2019. PubMed ID: 30995915). This variant was also documented in an individual with multiple types of cancer (Hodgkin lymphoma, lymphangioma, breast carcinoma); however, this individual also harbored chain-terminating variants in CDKN2A and PMS1 (http://www.oncm.org/v02p0088.htm). This variant is reported in 0.12% of alleles in individuals of South Asian descent in gnomAD and is interpreted as likely benign in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/238146/). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |